- 2022.02.28
- Thyas Co. Ltd., a Kyoto University spin-off, Closes JPY 2.1B Series B Financing from Eight Roads Ventures/F-Prime to Develop Novel iPSC-derived Immune Cell Platform
- 2021.11.12
- Change of board structure
- 2021.11.12
- Announcement of Series A3 financing
- 2021.09.01
- Joint research on personalized cancer immunotherapy using regenerated T cells derived from iPS cells
- 2021.05.18
- Dr. Shin Kaneko published a new article in Nature Biomedical Engineering.
- 2021.04.01
- New license agreement with iPS Academia Japan, Inc.
- 2021.02.01
- Basic agreement and joint research agreement with the CiRA Foundation
- 2021.01.27
- Dr. Shin Kaneko published a new article in Nature Communications.
- 2020.11.20
- Contract with Ki-CONNECT for academic advisory support.
- 2020.09.11
- Change of board structure.